gsk961081
Showing 1 - 5 of 5
Pulmonary Disease, Chronic Obstructive Trial in London (GSK961081, GSK961081 matching )
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK961081
- GSK961081 matching placebo
-
London, United KingdomGSK Investigational Site
Sep 28, 2021
Pulmonary Disease, Chronic Obstructive Trial in Harrow (GSK961081, GSK961081 matching , Propranolol)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK961081
- +3 more
-
Harrow, Middlesex, United KingdomGSK Investigational Site
Sep 28, 2021
Pulmonary Disease, Chronic Obstructive Trial in Randwick (GSK961081, Fluticasone furoate)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK961081
- Fluticasone furoate
-
Randwick, New South Wales, AustraliaGSK Investigational Site
May 12, 2017
Pulmonary Disease, Chronic Obstructive Trial in Germany, South Africa (GSK961081)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK961081
-
Mainz, Rheinland-Pfalz, Germany
- +4 more
Feb 1, 2017
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (GSK961081, Salmeterol, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK961081
- +2 more
-
Tallinn, Estonia
- +48 more
Nov 30, 2016